RESUMEN
In 2003, the first case series of six patients treated with an Atkins diet for epilepsy was published in the journal Neurology. The concept was a simple, outpatient-initiated diet in which ketosis could be maintained by eating high-fat foods while tracking and limiting daily carbohydrate counts based on food ingredient labels. Twenty years later, after dozens of studies encompassing hundreds of patients, including several randomized controlled trials, the Modified Atkins Diet is a proven method of providing ketogenic dietary therapy for epilepsy. It is a diet therapy of choice for adolescents and adults, is being investigated for new-onset epilepsy, and is researched for neurological conditions other than epilepsy. Adverse effects do exist but may be less common than the classic ketogenic diet. This review will cover the history, clinical trials, implementation, current utilization, and future directions of this "alternative" ketogenic diet therapy on its 20-year anniversary.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Dieta Cetogénica , Epilepsia , Adolescente , Adulto , Humanos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Dieta Cetogénica/efectos adversos , Epilepsia/dietoterapia , Cetosis/dietoterapiaRESUMEN
OBJECTIVE: The ketogenic diet therapy is a time-tested and potent non-pharmacologic treatment for epilepsy. However, the study of the ketogenic diet in patients with genetic generalized epilepsy (GGE) is not widely established. The aim of this study was to evaluate the efficacy and tolerability of the modified Atkins diet, a variation of the ketogenic diets, as a treatment for drug-resistant GGE. METHODS: A retrospective chart review was performed in patients with epilepsy treated with the modified Atkins diet at the University of Chicago from 2017 to 2020. For three months following diet initiation, participants were monitored for diet tolerability and effect on seizures. Response to the treatment was recorded by self-reporting patients and guardians. RESULTS: Thirteen patients with a diagnosis of drug-resistant GGE were identified. An average of 3.8 anti-seizure medications (ASMs) had been tried and 3.4 years had elapsed from seizure onset before dietary therapy was attempted. Patients were receiving a mean of 2.2 ASMs at the time of diet initiation. After undergoing dietary treatment for three months, 12/13 (92%) patients experienced a greater than 50% reduction in seizure frequency, 6/13 (46%) patients became seizure-free, and 7/13 (54%) were able to discontinue at least one ASM. All patients completed at least three months of dietary therapy with an average duration of 9.3 months at the time of report. One patient reported side effects of fatigue which may be attributed to the diet. SIGNIFICANCE: The modified Atkins diet has shown to be an effective and well-tolerated treatment for children with drug-resistant GGE. The diet provides the additional benefit of aiding to discontinue ASMs and, therefore, minimize the side effects from polypharmacy. Given these results, it seems reasonable to consider the modified Atkins diet as an alternative and possibly earlier treatment option for patients with drug-resistant GGE.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Dieta Cetogénica , Epilepsia Refractaria , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Epilepsia Generalizada , Epilepsia , Niño , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/métodos , Dieta Cetogénica/efectos adversos , Dieta Cetogénica/métodos , Epilepsia Refractaria/diagnóstico , Epilepsia Refractaria/tratamiento farmacológico , Humanos , Estudios Retrospectivos , Convulsiones , Resultado del TratamientoRESUMEN
BACKGROUND/AIMS: Ketogenic diet therapies (KDTs) offer a needed therapeutic option for patients with drug-resistant epilepsy. The current study investigated biochemical and anthropometric indices of cardiovascular disease (CVD) risk in adults with epilepsy treated with KDT over 6 months. METHOD: 65 adults with epilepsy naïve to diet therapy were enrolled in a prospective longitudinal study and instructed on modified Atkins diet (MAD) use. Seizure frequency, anthropometric measures, blood levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoproteins A1 and B, and lipoprotein sub-fractions were assessed at baseline, 3 months, and 6 months. RESULTS: Subsequent to study enrollment, 34 participants were lost to follow-up, elected not to start, or stopped MAD prior to study completion, leaving a total of 31 participants in the study at 6 months. Compared to baseline, participants on MAD showed significant reductions in median seizure frequency/week, weight, body mass index, waist and hip circumference, and percent body fat at 3 and 6 months. Compared to baseline, participants on MAD for 3 months showed significantly increased levels of total, small and medium LDL particles, ApoB and ApoB/A1 ratio. At 6 months, only small LDL particles and ApoB levels remained elevated and levels of ApoA1 had risen, suggesting possible compensatory adaptation over time. CONCLUSIONS: This study provides evidence demonstrating the efficacy and cardiovascular safety of 6 months of MAD use by adults with epilepsy. It also highlights an index of CVD risk - small LDL particles - that should be closely monitored.Trial registration: ClinicalTrials.gov identifier: NCT02694094..
Asunto(s)
Enfermedades Cardiovasculares , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Dieta Cetogénica , Epilepsia , Adulto , Apolipoproteínas B , Enfermedades Cardiovasculares/prevención & control , Colesterol , Dieta Baja en Carbohidratos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Dieta Cetogénica/efectos adversos , Humanos , Estudios Longitudinales , Estudios Prospectivos , Convulsiones , Resultado del TratamientoRESUMEN
Octanoic acid is a medium-chained saturated fatty acid found abundantly in the ketogenic dietary supplements containing medium chained triglycerides (MCT) along with decanoic acid. The MCT ketogenic diet is commonly consumed for weight loss but has also showcased neuroprotective potential against neurodegenerative disorders. However, recent clinical findings have reported a critical disadvantage with the long-term consumption of ketogenic diet i.e. bone loss. The following study was employed to investigate whether the two major components of MCT diet also possess bone loss potential as observed with classical ketogenic diet. Swiss albino mice aged between 10 and 12 weeks, were divided into 3 treatment groups that were administered with oral suspensions of octanoic acid, decanoic acid and a combination of both for 4 weeks. Bone specific markers, microarchitectural parameters, using micro computed tomography, and biomechanical strength were analyzed. Remarkably deleterious alterations in the trabecular bone microarchitecture, and on bone markers were observed in the octanoic acid treated groups. Our results suggest significant negative effects on bone health by octanoic acid. These findings require further investigation and validation in order to provide significant clinically relevant data to possibly modify dietary composition of the MCT ketogenic diet.
Asunto(s)
Resorción Ósea/inducido químicamente , Hueso Esponjoso/fisiopatología , Caprilatos/efectos adversos , Ácidos Decanoicos/farmacología , Dieta Cetogénica/efectos adversos , Suplementos Dietéticos/efectos adversos , Animales , Fenómenos Biomecánicos/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Fémur/fisiopatología , Cuerpos Cetónicos/orina , Masculino , Ratones , Fármacos Neuroprotectores/efectos adversos , Osteoclastos/efectos de los fármacos , Distribución Aleatoria , Tibia/fisiopatología , Triglicéridos/administración & dosificaciónRESUMEN
Carbohydrates are the major source of dietary energy, but their role in health and disease remains controversial. Recent epidemiological evidence suggests that the increased consumption of carbohydrates is associated with obesity and increased risk of mortality and dietary trials show that carbohydrate restriction leads to weight loss and improved glycaemic status in obese and diabetic subjects. In contrast, the diets of populations with long and healthy lifespans (e.g. traditional Okinawans from Japan) are high in carbohydrate and low in protein, and several clinical and preclinical studies have linked low-carbohydrate-high-protein diets with increased mortality risk. In this paper we attempt to reconcile these contradictory findings by moving beyond traditional single-nutrient analyses to consider the interactions between nutrients on health outcomes. We do so using the Geometric Framework (GF), a nutritional modelling platform that explicitly considers the main and interactive effects of multiple nutrients on phenotypic characteristics. Analysis of human data by GF shows that weight loss and improved cardio-metabolic outcomes under carbohydrate restriction derive at least in part from reduced caloric intake due to the concomitantly increased proportion of protein in the diet. This is because, as in many animals, a specific appetite for protein is a major driver of food intake in humans. Conversely, dilution of protein in the diet leverages excess food intake through compensatory feeding for protein ('protein leverage'). When protein is diluted in the diet by readily digestible carbohydrates and fats, as is the case in modern ultra-processed foods, protein leverage results in excess calorie intake, leading to rising levels of obesity and metabolic disease. However, when protein is diluted in the diet by increased quantities of less readily digestible forms of carbohydrate and fibre, energy balance is maintained and health benefits accrue, especially during middle age and early late-life. We argue that other controversies in carbohydrate research can be resolved using the GF methodology in dietary studies.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Carbohidratos de la Dieta/metabolismo , Síndrome Metabólico/metabolismo , Valor Nutritivo , Animales , Factores de Riesgo Cardiometabólico , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/fisiopatología , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Carbohidratos de la Dieta/efectos adversos , Ingestión de Energía , Metabolismo Energético , Femenino , Humanos , Masculino , Síndrome Metabólico/dietoterapia , Síndrome Metabólico/epidemiología , Síndrome Metabólico/fisiopatología , Estado Nutricional , Obesidad/dietoterapia , Obesidad/epidemiología , Obesidad/metabolismo , Obesidad/fisiopatología , Ingesta Diaria Recomendada , Medición de RiesgoRESUMEN
BACKGROUND AND AIMS: The overall macronutrient composition of diet, rather than just calorie intake, may influence long-term changes of anthropometry. We investigated relationships between dietary macronutrient composition and long-term changes in weight and waist circumference in participants of the EPIC-Italy - the Italian section of the European Prospective Investigation into Cancer and Nutrition - study. METHODS AND RESULTS: A total of 32,119 participants provided anthropometric measures at recruitment and 12 years later (mean). Diet at recruitment was assessed using validated semi-quantitative food frequency questionnaires. Weight and waist changes associated with replacing 10% of energy from one macronutrient with 10% of energy from another macronutrient were assessed by multivariable linear regression. Increased energy from total protein at the expense of any other macronutrient was significantly associated with increased weight and waist circumference. Increased starch at the expense of sugar and total protein was associated with significantly decreased weight and waist circumference; when starch replaced total fat, weight significantly decreased. Increased sugar at the expense of starch and total fat was significantly associated with increased weight and waist circumference; but increase at the expense of total protein was significantly associated with decreased weight and waist circumference. CONCLUSION: Our results suggest that increasing protein at the expense of fat or carbohydrates, and reducing starch by increasing other macronutrients, might be associated with increased weight and waist gain.
Asunto(s)
Trayectoria del Peso Corporal , Dieta/efectos adversos , Nutrientes/efectos adversos , Valor Nutritivo , Obesidad/epidemiología , Circunferencia de la Cintura , Adulto , Dieta con Restricción de Grasas/efectos adversos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Ingestión de Energía , Femenino , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Encuestas Nutricionales , Obesidad/diagnóstico , Estudios Prospectivos , Factores de TiempoRESUMEN
OBJECTIVE: To investigate whether low-carbohydrate diets (LCDs) were associated with coronary artery calcium (CAC) progression. Approach and Results: We included the participants who completed computed tomography assessment of baseline CAC in 2000 to 2001 (year 15) and follow-up (year 20 or 25) and food frequency questionnaire (years 0, 7, and 20) in the CARDIA study (Coronary Artery Risk Development in Young Adults). CAC progression was defined as CAC >0 at follow-up among participants with baseline CAC of 0 and an annualized change of 10 or percent change of ≥10% for those with 0Asunto(s)
Enfermedad de la Arteria Coronaria/epidemiología
, Dieta Baja en Carbohidratos/efectos adversos
, Calcificación Vascular/epidemiología
, Adolescente
, Adulto
, Factores de Edad
, Angiografía por Tomografía Computarizada
, Angiografía Coronaria
, Enfermedad de la Arteria Coronaria/diagnóstico por imagen
, Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos
, Progresión de la Enfermedad
, Ingestión de Energía
, Femenino
, Humanos
, Estudios Longitudinales
, Masculino
, Valor Predictivo de las Pruebas
, Estudios Prospectivos
, Medición de Riesgo
, Factores de Riesgo
, Factores de Tiempo
, Estados Unidos/epidemiología
, Calcificación Vascular/diagnóstico por imagen
, Adulto Joven
RESUMEN
PURPOSE OF REVIEW: High-protein intake is commonly recommended to help people manage body weight. However, high-protein intake could have adverse health consequences. Here we review the latest findings concerning the effect of high-protein intake on cardiometabolic health. RECENT FINDINGS: Calorie-reduced, high-protein, low-carbohydrate diets lower plasma glucose in people with type 2 diabetes (T2D). However, when carbohydrate intake is not markedly reduced, high-protein intake often does not alter plasma glucose and increases insulin and glucagon concentrations, which are risk factors for T2D and ischemic heart disease. High-protein intake does not alter plasma triglyceride and cholesterol concentrations but promotes atherogenesis in animal models. The effect of high-protein intake on liver fat remains unclear. In population studies, high-protein intake is associated with increased risk for T2D, nonalcoholic fatty liver disease, and possibly cardiovascular diseases. SUMMARY: The relationship between protein intake and cardiometabolic health is complex and influenced by concomitant changes in body weight and overall diet composition. Although a high-protein, low-carbohydrate, reduced-energy diet can have beneficial effects on body weight and plasma glucose, habitual high-protein intake, without marked carbohydrate and energy restriction, is associated with increased cardiometabolic disease risk, presumably mediated by the changes in the hormonal milieu after high-protein intake.
Asunto(s)
Enfermedades Cardiovasculares/etiología , Dieta Rica en Proteínas/efectos adversos , Proteínas en la Dieta/efectos adversos , Obesidad/sangre , Animales , Glucemia/metabolismo , Factores de Riesgo Cardiometabólico , Colesterol/sangre , Diabetes Mellitus Tipo 2/etiología , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Glucagón/sangre , Humanos , Insulina/sangre , Enfermedad del Hígado Graso no Alcohólico/etiología , Obesidad/complicaciones , Triglicéridos/sangreRESUMEN
Alcohol abuse is positively associated with cardiovascular disease. Dietary low-carbohydrate/high-protein (LCHP) intake confers a greater mortality risk. Here, the impact of ethanol consumption in combination with dietary LCHP intake on left ventricular (LV) systolic function and lethal ventricular arrhythmia susceptibility were investigated in apolipoprotein E/low-density lipoprotein receptor double-knockout (AL) mice. The underlying mechanisms, cardiac sympathovagal balance, beta-adrenergic receptor (ADRB) levels, and gap junction channel protein connexin 43 (Cx43) expression, were examined. Male AL mice fed an LCHP diet with or without ethanol were bred for 16 weeks. Age-matched male AL and wild-type mice received standard chow diet and served as controls. The following were used to assess LV systolic function, lethal ventricular arrhythmia susceptibility, cardiac sympathovagal balance, Cx43 expression, and ADRB levels: The results demonstrated that ethanol consumption in combination with dietary LCHP intake worsened LCHP-induced LV systolic dysfunction in AL mice and enhanced their susceptibility in the ventricular arrhythmia-evoked test. There were concomitant increases in LV weight, LF/HF ratio shown by HRV, TH, ADRB1, ADRB2, and Cx43 expressions by LV fluorescence immunohistochemistry, and LV Cx43 messenger ribonucleic acid expression by PCR. In AL mice, alcohol consumption combined with dietary LCHP intake may thus promote a shift in cardiac sympathovagal balance toward sympathetic predominance, the increases in beta-adrenergic receptors (ADRB1 and ADRB2), and then affect the gap junction channel protein Cx43, which in turn could contribute to increased risks of LV systolic dysfunction and susceptibility to lethal ventricular arrhythmia.
Asunto(s)
Consumo de Bebidas Alcohólicas , Arritmias Cardíacas , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Disfunción Ventricular Izquierda/inducido químicamente , Consumo de Bebidas Alcohólicas/efectos adversos , Animales , Apolipoproteínas/genética , Arritmias Cardíacas/inducido químicamente , Conexina 43 , Lipoproteínas LDL/genética , Masculino , Ratones , Ratones NoqueadosRESUMEN
Carbohydrate-restricted diets are increasingly recognized as options for dietary management of type 2 diabetes mellitus (T2DM). We investigated the effects of a carbohydrate-reduced high-protein (CRHP) and a conventional diabetes (CD) diet on oxidative stress and inflammation in weight stable individuals with T2DM. We hypothesized that the CRHP diet would improve markers of oxidatively generated RNA and DNA modifications as well as inflammatory parameters. Thirty participants with T2DM were randomized to 6 weeks of CRHP or CD dietary treatment (30/50 energy percentage (E%) carbohydrate, 30/17E% protein, 40/33E% fat), followed by a cross-over to the opposite diet for a subsequent 6-week period. All meals were provided during the study and body weight was controlled. Diurnal urine samples were collected after 4 weeks on each diet and oxidatively generated RNA and DNA modifications were measured as 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), respectively. Fasting concentrations of soluble urokinase plasminogen activator receptor, high-sensitivity C-reactive protein, tumor necrosis factor alpha and interleukin-6 were measured before and after 6 weeks of interventions. Compared with the CD diet, the CRHP diet increased 24-hour urinary excretion of 8-oxoGuo by 9.3% (38.6 ± 12.6 vs. 35.3 ± 11.0 nmol/24 h, p = .03), whereas 8-oxodG did not differ between diets (24.0 ± 9.5 vs. 24.8 ± 11.1 nmol/24 h, p = .17). Changes in plasma inflammatory parameters did not differ between CRHP and CD diets, all p ≥ .2. The clinical implications of increased RNA oxidation following a CRHP diet as well as long-term effects of carbohydrate-restriction on markers of oxidatively generated nucleic acid modifications should be a field of future study.
Asunto(s)
8-Hidroxi-2'-Desoxicoguanosina/orina , Diabetes Mellitus Tipo 2/orina , Dieta para Diabéticos/métodos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Guanosina/análogos & derivados , Ácidos Nucleicos/orina , Anciano , Glucemia/metabolismo , Índice de Masa Corporal , Peso Corporal , Proteína C-Reactiva/orina , Estudios Cruzados , Diabetes Mellitus Tipo 2/sangre , Femenino , Hemoglobina Glucada/metabolismo , Guanosina/orina , Humanos , Inflamación , Interleucina-6/orina , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Estrés Oxidativo , Receptores del Activador de Plasminógeno Tipo Uroquinasa/metabolismo , Factor de Necrosis Tumoral alfa/orinaRESUMEN
OBJECTIVE: The aim was to examine the influence of modified Atkins diet on serum concentration of antiepileptic drugs (AEDs). METHODS: Prospective data from 63 adult patients with either focal or generalized drug-resistant epilepsy recruited to 12-week dietary treatment as add-on to AEDs are analyzed. AED serum concentrations, ketones, glucose, and hemoglobin A1c were measured before and after the dietary intervention. Paired t test was used and Spearman correlation coefficient, r, was estimated. RESULTS: Mean age was 37 years (range 16-65 years). Mean serum concentrations of carbamazepine, clobazam, and valproate were significantly reduced after 4 and 12 weeks of the diet period (<.001 ≤ P ≤ .02). Levels of lacosamide, lamotrigine, and topiramate were less reduced (.02 ≤ P ≤ .08), whereas the serum concentrations of oxcarbazepine, zonisamide, and levetiracetam were unchanged (.06 ≤ P ≤ .90). The largest reduction in serum concentration was found for clobazam: mean reduction after 12 weeks was 1.5 µmol/L (34%). Percent change in serum concentration after 4 and 12 weeks of all drugs analyzed was -10.5% (95% confidence interval [CI] -14.1 to -6.8; n = 60; P < .001) and -13.5% (95% CI -18.8 to -8.3; n = 56; P < .001), respectively. Percent change in serum concentration of AEDs was not significantly correlated to percent change in seizure frequency after 12 weeks of dietary treatment (r = .14, P = .33, n = 53) but negatively correlated to urine ketosis (r = -.43; P = .003; n = 46). SIGNIFICANCE: A reduction in AED serum concentrations may counteract a seizure-reducing effect of the diet, and in patients without such an effect, it may cause seizure aggravation. Thus, we recommend that clinicians who are treating patients with ketogenic diets monitor serum concentrations of the concomitant AEDs.
Asunto(s)
Anticonvulsivantes/sangre , Anticonvulsivantes/uso terapéutico , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Epilepsia Refractaria/sangre , Epilepsia Refractaria/tratamiento farmacológico , Interacciones Alimento-Droga/fisiología , Adolescente , Adulto , Anciano , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto JovenRESUMEN
BACKGROUND: Metabolic disorders (e.g., impaired glucose tolerance, insulin resistance, and type 2 diabetes) are more prevalent in people with spinal cord injury (SCI) than able-bodied individuals. Dietary modification is a more cost-effective treatment option than pharmacological therapies for reducing the risk of metabolic dysfunction. Lowering carbohydrate, increasing protein, and maintaining a proper dietary fat intake are expected to induce favorable adaptations in glucose control, body fat distribution, and the composition of the gut microbiome. However, dietary modification has not been rigorously investigated in people with SCI. The purpose of this study is to determine if an 8-week low-carbohydrate/high-protein (LC/HP) dietary intervention will show improvements in clinically important metrics of metabolic function, body composition, the composition of gut bacteria, and quality of life. METHODS/DESIGN: We intend to recruit 100 participants with chronic traumatic SCI (3 years postinjury, C5-L2, American Spinal Injury Association impairment scale A-D, and aged 18-65 years) and insulin resistance, impaired glucose tolerance or untreated type 2 diabetes and randomly assign them to an 8-week LC/HP dietary intervention group or a control group. The daily LC/HP dietary intervention includes ~ 30% total energy as protein (1.6 g/kg per day) with a carbohydrate-to-protein ratio < 1.5 and fat intake set at ~ 30% of the total energy intake. The control group does not receive any dietary intervention and are continuing with their regular daily diets. Glucose tolerance, insulin sensitivity, ß-cell function, body composition, gut microbiome composition, and quality of life measures are assessed at week 1, before starting the LC/HP dietary intervention, and at week 8, after completion of the LC/HP dietary intervention. DISCUSSION: New information derived from this project will result in the development of a low-cost, simple, self-administered LC/HP dietary intervention for improving metabolic function in individuals with chronic SCI, improved understanding of the composition of gut bacteria in SCI, and how a LC/HP dietary intervention alters gut bacteria composition. In addition, this project will improve our understanding of the relationship between metabolic function and quality of life in individuals with long-standing SCI. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03207841. Registered on 5 June 2017.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Ingestión de Energía , Metabolismo Energético , Enfermedades Metabólicas/dietoterapia , Valor Nutritivo , Traumatismos de la Médula Espinal/dietoterapia , Adolescente , Adulto , Anciano , Alabama , Biomarcadores/sangre , Composición Corporal , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Femenino , Microbioma Gastrointestinal , Estado de Salud , Humanos , Masculino , Enfermedades Metabólicas/sangre , Enfermedades Metabólicas/microbiología , Enfermedades Metabólicas/fisiopatología , Persona de Mediana Edad , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto , Traumatismos de la Médula Espinal/sangre , Traumatismos de la Médula Espinal/microbiología , Traumatismos de la Médula Espinal/fisiopatología , Factores de Tiempo , Resultado del Tratamiento , Adulto JovenRESUMEN
Objective: To assess the safety and tolerability of a modified Atkins diet (KDMAD), a type of ketogenic diet (KD), in subjects with relapsing MS while exploring potential benefits of KDs in MS. Methods: Twenty subjects with relapsing MS enrolled into a 6-month, single-arm, open-label study of the KDMAD. Adherence to KDMAD was objectively monitored by daily urine ketone testing. Fatigue and depression scores and fasting adipokines were obtained at baseline and on diet. Brain MRI was obtained at baseline and 6 months. Intention to treat was used for primary data analysis, and a per-protocol approach was used for secondary analysis. Results: No subject experienced worsening disease on diet. Nineteen subjects (95%) adhered to KDMAD for 3 months and 15 (75%) adhered for 6 months. Anthropometric improvements were noted on KDMAD, with reductions in body mass index and total fat mass (p < 0.0001). Fatigue (p = 0.002) and depression scores (p = 0.003) were improved. Serologic leptin was significantly lower at 3 months (p < 0.0001) on diet. Conclusions: KDMAD is safe, feasible to study, and well tolerated in subjects with relapsing MS. KDMAD improves fatigue and depression while also promoting weight loss and reducing serologic proinflammatory adipokines. Classification of evidence: The study is rated Class IV because of the absence of a non-KD control group.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Dieta Cetogénica/efectos adversos , Esclerosis Múltiple Recurrente-Remitente/dietoterapia , Adipoquinas , Adolescente , Adulto , Antropometría , Índice de Masa Corporal , Depresión/prevención & control , Fatiga/prevención & control , Femenino , Humanos , Inflamación/prevención & control , Masculino , Persona de Mediana Edad , Esclerosis Múltiple Recurrente-Remitente/sangre , Proyectos Piloto , Resultado del Tratamiento , Pérdida de PesoRESUMEN
BACKGROUND: Dietary nutrient intake and its metabolism by the gut microbiome have recently been implicated in cardiovascular disease (CVD) risk. In particular, trimethylamine N-oxide (TMAO), a metabolite of the gut microbiota, has been shown to be a predictor of incident CVD events. Elevated levels of branched-chain amino acids (BCAA) have also been associated with an increased propensity for insulin resistance. METHODS: To study the association of dietary intake with systemic TMAO, its nutrient precursors, and BCAA levels on fasting plasma levels of TMAO and its nutrient precursors and BCAA, we conducted an exploratory post-hoc analysis of 3 popular diets - high fat (Atkins), Mediterranean (South Beach), and very low fat (Ornish) - using plasma samples from a prior randomized, crossover study, with each isocaloric dietary phase lasting 4 weeks. Metabolites were quantified using stable isotope dilution HPLC with on-line tandem mass spectrometry. RESULTS: Compared to the low fat Ornish phase, the high fat Atkins dietary phase was characterized by increased levels of TMAO (3.3 vs. 1.8 µM, p = 0.01), and the BCAA valine (272.8 vs. 235.8 µM, p = 0.005) and leucine (105.9 vs. 96.4 µM, p = 0.01). The high fat Atkins dietary phase was also associated with higher levels of TMAO (3.3 vs 1.6 µM, p = 0.04), valine (272.8 vs. 240.7 µM, p = 0.004), and leucine (105.9 vs. 96.4 µM, p = 0.01) compared to baseline. CONCLUSIONS: These data suggest that over a 4-week interval, a saturated fat diet that is predominantly animal-based, compared to an isocaloric, low fat, predominantly plant-based diet, is associated with heightened risk for cardiometabolic derangements, as monitored by a higher plasma levels of both TMAO and BCAA.
Asunto(s)
Aminoácidos de Cadena Ramificada/sangre , Bacterias/metabolismo , Enfermedades Cardiovasculares/etiología , Dieta con Restricción de Grasas , Dieta Alta en Grasa/efectos adversos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Dieta Mediterránea , Microbioma Gastrointestinal , Metilaminas/sangre , Biomarcadores/sangre , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/diagnóstico , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo , Factores de Riesgo , Factores de TiempoRESUMEN
OBJECTIVE: The aim of this article was to assess the association between low-carbohydrate high-protein (LCHP) diet score and the risk of incident chronic kidney disease (CKD). DESIGN AND METHODS: This cohort study was conducted on 1,797 Iranian participants, aged ≥20 years, followed-up for a mean of 6.1 years. Using a valid and reliable food-frequency questionnaire at baseline, LCHP diet score between 0 and 12 points were determined. Anthropometric measures and biochemical indicators were assessed. Participants were classified based on their estimated glomerular filtration rate (eGFR) levels using the National Kidney Foundation guidelines; eGFR ≥ 60 mL/minute/1.73 m2 as not having CKD and eGFR < 60 mL/minute/1.73 m2 as having CKD. Multivariable logistic regression was used to estimate the odds ratio for the occurrence of CKD according to the tertiles of LCHP diet score. RESULTS: Mean (standard) age of participants (48% male) was 37.7 (12.2) years at baseline. The median (25-75 interquartile range) of LCHP diet for all subjects was 7 (4-8), and incidence of CKD was 14.1%. After adjusting for age, sex, smoking status, physical activity, total calorie intake, body mass index, diabetes, hypertension, and baseline eGFR, participants in the highest tertile of LCHP diet had greater risk of incident CKD (odds ratio: 1.48; 95% confidence interval: 1.03-2.15), in comparison to those in the lowest one (P for trend = .027). CONCLUSION: Our findings demonstrate the hypothesis that higher score of LCHP diet may have adverse effects on incidence and development of CKD.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Insuficiencia Renal Crónica/epidemiología , Adulto , Causalidad , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Tasa de Filtración Glomerular , Humanos , Incidencia , Irán/epidemiología , Masculino , Estudios Prospectivos , Factores de RiesgoRESUMEN
PURPOSE: To determine whether use of a ketogenic formula during the first month of the modified Atkins diet (MAD) in adults with drug-resistant epilepsy (DRE) improves seizure reduction and compliance compared to MAD alone. METHODS: Eighty adults (age ≥18 years) with DRE and ≥4 reliably quantifiable seizures/month were enrolled. All participants were trained to follow a 20â¯g/day net carbohydrate limit MAD. Patients were randomized to receive one 8-ounce (237â¯mL) tetrapak of KetoCal®, a 4:1 ketogenic ratio formula, daily in combination with MAD during the first month (treatment arm) or second month (control/cross-over arm). Patients recorded urine ketones, weight, and seizure frequency and followed up at 1 and 2 months. RESULTS: By 1 month, 84% of patients achieved ketosis (median of 4-4.5 days). At 1 month, the treatment arm had a significantly higher ketogenic ratio and more patients with a ≥1:1 ketogenic ratio compared to the control arm. There was no difference in median seizure frequency, proportion of responders (≥50% seizure reduction), or median seizure reduction from baseline between groups. However, patients treated with KetoCal® during the first month were significantly more likely to continue MAD for 6 months or more. CONCLUSION: Although supplementing MAD with a ketogenic formula in the first month did not increase the likelihood of reducing seizures compared to MAD alone, significantly more adults remained on MAD long-term with this approach. This suggests a potential strategy for encouraging compliance with MAD in adults with DRE.
Asunto(s)
Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/métodos , Epilepsia Refractaria/dietoterapia , Cooperación del Paciente , Adulto , Peso Corporal , Estudios Cruzados , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Dieta Cetogénica/efectos adversos , Dieta Cetogénica/métodos , Epilepsia Refractaria/orina , Femenino , Estudios de Seguimiento , Humanos , Cetosis/dietoterapia , Cetosis/orina , Masculino , Convulsiones/dietoterapia , Convulsiones/orina , Factores de Tiempo , Resultado del TratamientoRESUMEN
AIM: The current study investigated biochemical and vascular markers of cardiovascular health in adult patients with epilepsy treated with long-term (greater than 1year) ketogenic diet therapy compared with controls. METHOD: Anthropometric measures, serum fasting lipid panel, apolipoproteins A-1 and B, lipoprotein sub-fractions as well as common carotid intima-media thickness (cIMT), and plaque presence were assessed in 20 adult patients with epilepsy on a modified Atkins diet (MAD) for >1year started as an adult compared with 21 adult patients with epilepsy naïve to diet therapy. RESULTS: Patients treated with MAD had significantly lower weight, body mass index, waist and hip circumference, percent body fat, and serum triglyceride levels when compared with control patients. In contrast, they had significantly higher serum levels of small low-density-lipoprotein (LDL) particles and were significantly more likely to have LDL pattern B in which small LDL particles predominate when compared with controls. However, there was no significant difference in cIMT or plaque presence between groups. CONCLUSION: Our results provide clinical evidence demonstrating the cardiovascular safety of a high-fat, low-carbohydrate diet used in adults with epilepsy for at least 12months. It also highlights potential markers of cardiovascular risk - small dense LDL particles - that should be closely monitored in adults treated with diet therapy long-term.
Asunto(s)
Arterias Carótidas/fisiopatología , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/métodos , Epilepsia/dietoterapia , Epilepsia/fisiopatología , Adulto , Biomarcadores/sangre , Índice de Masa Corporal , Peso Corporal , Grosor Intima-Media Carotídeo , Dieta Baja en Carbohidratos/métodos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Epilepsia/sangre , Femenino , Humanos , Lipoproteínas LDL/sangre , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Despite the well-documented importance of nutrition in optimizing performance and health, the dietary intake of soccer players has attracted little attention. AIM: We aimed to assess the pre-season dietary intake of professional soccer players and its adequacy in macro and micronutrients. METHODS: The pre-season dietary intake of 19 male athletes was assessed using a semi-structured 3-day food record. To determine dietary adequacy and excess, energy and macronutrient intake were compared with the Brazilian dietary reference values for athletes, and micronutrients were compared with the Estimated Average Requirement - EAR (minimum recommendation) and Tolerable Upper Intake Level - UL (maximum recommendation). RESULTS: Mean daily energy intake (40.74±12.81 kcal/kg) was adequate. However, there was a low carbohydrate intake (5.44±1.86 g/kg/day) and a high amount of protein and fat (1.91±0.75 and 1.27±0.50 g/kg/day, respectively). Sodium intake (3141.77±939.76 mg/day) was higher than UL (2300 mg/day), while the majority of players showed daily intake of vitamin A (74%), vitamin D (100%), folate (58%), calcium and magnesium (68%) below the EAR (625, 10 and 320 µg/day, 800 and 330 mg/day, respectively). CONCLUSION: The dietary intake of professional soccer players was adequate in energy, but inadequate in macro and micronutrients, which suggests the need to improve nutritional practices to sustain the physical demands of soccer during pre-season.
Asunto(s)
Atletas , Dieta Saludable , Cooperación del Paciente , Fenómenos Fisiológicos en la Nutrición Deportiva , Adolescente , Adulto , Brasil/epidemiología , Enfermedades Carenciales/epidemiología , Enfermedades Carenciales/etiología , Enfermedades Carenciales/fisiopatología , Enfermedades Carenciales/prevención & control , Registros de Dieta , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Ingestión de Energía , Humanos , Masculino , Prevalencia , Ingesta Diaria Recomendada , Riesgo , Estaciones del Año , Índice de Severidad de la Enfermedad , Fútbol , Adulto JovenRESUMEN
BACKGROUND: Excessive weight gain is commonly observed within the first year after kidney transplantation and is associated with negative outcomes, such as graft loss and cardiovascular events. The purpose of this study is to evaluate the effect of a high protein and low glycemic-index diet on preventing weight gain after kidney transplantation. METHODS: We designed a prospective, single-center, open-label, randomized controlled study to compare the efficacy of a high protein (1.3-1.4 g/kg/day) and low-glycemic index diet versus a conventional diet (0.8-1.0 g/kg/day of protein) on preventing weight gain after kidney transplantation. A total of 120 eligible patients 2 months after transplantation will be recruited. Patients with an estimated glomerular filtration rate through the modification of diet of renal disease (MDRD) formula < 30 mL/min/1.73 m2 or urinary albumin excretion > 300 mg/24 h will be excluded. Patients' diets will be allocated through simple sequential randomization. Patients will be followed-up for 12 months with nine clinic appointments with a dietitian and the evaluations will include nutritional assessment (anthropometrics, body composition, and resting metabolic rate) and laboratory tests. The primary outcome is weight maintenance or body weight gain under 5% after 12 months. Secondary outcomes include body composition, resting metabolic rate, satiety sensation, kidney function, and other metabolic parameters. DISCUSSION: Diets with higher protein content and lower glycemic index may lead to weight loss because of higher satiety sensation. However, there is a concern about the association of high protein intake and kidney damage. Nevertheless, there is little evidence on the impact of high protein intake on long-term kidney function outcome. Therefore, we designed a study to test if a high protein diet with low-glycemic index will be an effective and safe nutritional intervention to prevent weight gain in kidney transplant patients. TRIAL REGISTRATION: ClinicalTrials.gov identifier, NCT02883777 . Registered on 3 August 2016.
Asunto(s)
Índice Glucémico , Trasplante de Riñón , Riñón/cirugía , Receptores de Trasplantes , Pérdida de Peso , Composición Corporal , Brasil , Protocolos Clínicos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Tasa de Filtración Glomerular , Humanos , Riñón/fisiopatología , Trasplante de Riñón/efectos adversos , Estado Nutricional , Estudios Prospectivos , Proyectos de Investigación , Respuesta de Saciedad , Factores de Tiempo , Resultado del TratamientoRESUMEN
BACKGROUND: Zinc has a critical role in metabolism and growth. This study aims to determine the effects of low-energy diets differing in macronutrient composition on zinc intake, estimated zinc bioavailability (phytate:zinc molar ratio) and plasma zinc concentration and associations between zinc status and cardiometabolic markers in obese adolescents with clinical insulin resistance (IR). METHODS: Eighty-seven obese adolescents (10-17 years, body mass index z-score 2.3 ± 0.37) with clinical IR were randomized to a low-energy diet (6.0-8.0 MJ), which was either high carbohydrate or moderate carbohydrate with increased protein. Twenty-four-hour dietary recalls were collected at 6, 9 and 12 weeks. Plasma zinc concentration and cardiometabolic markers were assessed at baseline and 12 weeks. RESULTS: Zinc intake did not differ between the 2 diet groups (p = 0.612). The high-carbohydrate group had a higher phytate intake (894 vs. 671 mg, p = 0.018) and phytate:zinc molar ratio (9.4 vs. 7.4, p = 0.009) than the increased-protein group. Plasma zinc concentration did not change from baseline in either of the diet groups, but correlated positively with zinc intake (r = 0.235, p = 0.042) and % energy from protein (r = 0.383, p = 0.001), and inversely with % energy from carbohydrate (r = -0.296, p = 0.010). CONCLUSIONS: Low energy diets for obese adolescents at risk of diabetes may need increased protein content to optimize zinc bioavailability.